Move Free

Ultra Triple Action

D
N+ Score63
Collagen & BeautyServing: 1 Tablet(s)Type: Other Combinations

Move Free Ultra Triple Action is an 'Other Combinations' supplement, classified under Collagen & Beauty, featuring 4 total ingredients with complete label transparency. This product includes a Proprietary Cartilage Blend (40mg), Boron (5mg), and Hyaluronic Acid (3.3mg). However, none of the ingredients in this formulation are present at dosages considered clinically effective based on current research, indicating potential underdosing. The product receives an N+ Score of 63, earning a 'D' grade, placing it in the average tier. Its ingredient adequacy is 50%, and formula completeness is 33%, suggesting a narrow focus without robust ingredient levels. This supplement may be considered by individuals exploring general joint support, though specific clinical benefits are not strongly supported by the ingredient dosages.

About This Product

Ultra Triple Action by Move Free is a collagen & beauty supplement containing 4 active ingredients. It has earned an N+ Score of 63/100 (Grade D).

N+ Score Breakdown

Ingredient Adequacy50/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness33/100

Does the product include all expected ingredients for its supplement category?

Label Transparency100/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity86/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms

Weaknesses

  • Missing several expected ingredients for its category

Ingredient Analysis (4 ingredients)

IngredientAmountDose Adequacy
Boron5.000 mgN/A
Sodium10.000 mgN/A
Hyaluronic Acid3.300 mgN/A
Proprietary Cartilage Blend40.000 mgN/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.